We invested in Agile Devices because it is working on an important technical problem in interventional care: improving vascular navigation through better microcatheter technology. We are attracted to medtech businesses that address procedural efficiency, operator control, and real-world care challenges in ways that can reduce time, cost, and risk. Agile Devices reflects that kind of focused problem solving. The company also matches our view that device innovation can be compelling when it improves procedural execution in ways clinicians can feel immediately. We believe technologies that make interventions more precise and more efficient can have meaningful value in complex care settings, especially when they address clear operator pain points.